Researchers from the Singapore-MIT Alliance for Research and Technology have devised a way to diagnose malaria using magnetic resonance relaxometry, a similar technology to MRI.

When lunchtime hits, are you more tempted by fried foods than a fresh salad? Researchers at Tufts University have shown it may be possible to train your brain to think healthy foods taste better than unhealthy ones.

The cancer detection rate was significantly lower for breast MRI screenings than for diagnostic MRIs, according to a study published in the September issue of the Journal of the American College of Radiology.

In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared to the use of conventional IHC-FISH pathology tests.

The Wagner-Torizuka fellowship, created by Henry N. Wagner, Jr., MD, and Kanji Torizuka, MD, PhD, provides Japanese clinicians in the field of molecular imaging a major platform for advanced training and research. Three physicians have been honored with the fellowship, SNMMI announced yesterday. 

A targeted molecular imaging technique could aid in the prevention of blindness associated with progressive diabetic neuropathy by tracking alterations in the retinal endothelium, the Federation of American Societies for Experimental Biology (FASEB) announced yesterday.

The FDA has approved SenoClaire, GE’s breast tomosynthesis device that was developed in collaboration with Massachusetts General Hospital.

The amyloid PET radiotracer F-18 flutemetamol (Vizamyl) has been given the CE mark from the European Commission authorizing marketing of the drug across Europe, GE Healthcare announced yesterday.